European Journal of Medicinal Chemistry p. 595 - 602 (1990)
Update date:2022-08-02
Topics:
Howson
Armstrong
Cassidy
Novelli
Tchorzewska
Jaxa-Chamiec
Dolle
Hallam
Leigh
Merritt
Moores
Rink
Receptor mediated calcium entry (RMCE) is a now recognised mechanism by which the influx of Ca2+ into cells can occur. Agents which antagonise or block this mechanism are expected to possess anti-platelet aggregation and anti-inflammatory activities. The first series of RMCE blockers based upon the lead compound SC 38249, has been prepared. Their synthesis, activity against ADP evoked Ca2+ signals in human platelets and their anti-platelet aggregation activity is described. A trend between the c log P of these compounds and their activity as inhibitors of Ca2+ influx into human platelets stimulated by ADP was observed. This SAR study led to a 40-fold increase in activity over the initial lead compound.
View MoreAnhui Redstar Pharmaceutical Corp., Ltd
Contact:+86-563-5120837
Address:Jingxian Industrial Development Zone, Anhui , China
Shanghai Yingrui Biopharma Co., Ltd
Contact:021-3358 8661*8003
Address:shanghai
Kunshan Yalong Trading Co,.Ltd
Contact:86-512-57621185
Address:805-807 Room Hongqiao Mansion ,1088 West Qianjin Road, Kunshan, Jiangsu,China
Contact:+86-519-86623222
Address:29F/D, 99 Yanling West Road, Changzhou, Jiangsu, China
Contact:+852 83038667
Address:Room 1502, 15th Floor, SPA Centre,53-55 Lockhart Road, Wanchai, Hong Kong
Doi:10.1016/S0040-4020(01)96012-0
(1990)Doi:10.1016/0022-328X(90)85478-H
(1990)Doi:10.1002/anie.201101524
(2011)Doi:10.1021/jo00172a056
(1983)Doi:10.1055/s-1990-27095
(1990)Doi:10.1016/S0040-4020(01)87896-0
(1990)